MyBlueDotsATCC Announces Award from NCI to Support Research and Vaccine Development for Cancer and HIV MyBlueDots6 months ago01 mins MANASSAS, Va.–(BUSINESS WIRE)– #CancerResearch–ATCC has been awarded a five-year, IDIQ contract by NCI to provide lab services to support AMRVS with research and vaccine development. Post navigation Previous: XiFin Celebrates National Pharmacist Day with Early Insights From 2025 Pharmacy SurveyNext: Montecito Medical Named Key Influencer in Healthcare Real Estate
Engineers create first immunocompetent leukemia device for CAR T immunotherapy screening MyBlueDots2 days ago 0
Improvements to patient recovery strategies lower long-term opioid usage after colorectal surgery MyBlueDots2 days ago 0